If you want to know about DIVISLAB Ltd’s share price target for the upcoming years 2022, 2023, 2024, 2025, and 2030? then you are reading the best article about it.
After reading the full article you will have the all upcoming targets and my fundamental analysis with research. Divis Lab is India’s second most popular and valuable pharmaceutical and drug company. The present CEO of Divis Lab is Mr. Satchandra Kiran Divi. Let’s start.
Divi’s Laboratories Limited is an Indian multinational company that deals in the pharmaceutical sector. They are mainly involved in the production of APIS which have highly dependent on the worldwide market. They have more than 350 Scientists who work there for producing life-saving at a viable price.
DIVISLAB Ltd Quarterly Report Analysis
In the first quarter of the financial year, 2021 company made net sales of around Rs.1,950.16 Cr. and they make out of it around Rs.551.97 Cr. in the second quarter of the same financial year 2021, they make net sales of Rs.1,967.86 Cr. and make a profit of around Rs.606.39 Cr. same in the third quarter of the financial year 2021 they make sales of Rs.2,466.77 Cr. and profit of around Rs.907.22 Cr. which is pretty much higher than other quarters which is the reason for their deals with other pharmaceutical companies for their research-based product.
In the last quarter of 2021, they make net sales of around Rs.2,495.03 Cr. and make a profit of it around Rs.882.96 Cr. and in the first quarter of the financial year, 2022 company made net sales of about Rs.2,203.92 Cr. and make a profit from it of around Rs.691.61 Cr.
DIVISLAB Ltd Annual Report Analysis
In the year 2017, the company made net sales of around Rs.4,023.85 Cr. and make a profit it of about Rs.1,053.27 Cr. in that year Divis Lab develops its infrastructure for research-based projects. In the following year 2018, they make net sales of Rs.3,815.94 Cr. and make a profit of it around Rs.869.58 Cr. which is pretty much lower than other years as concerned because of the earlier reason which I mentioned in the year 2017. In the next year which is 2019, they make sales of about Rs.4,879.66 Cr. and make a profit off it around Rs.1,332.65 Cr.
In the year 2020, they make sales of Rs.5,310.57 Cr., and a profit of around Rs.1,372.71 Cr. which is higher than the last 3 years which is the result of their investment in a research-based project. in the year 2021, they make sales of around Rs.6,798.61 Cr. and make a profit of about Rs.1,954.72 Cr. and in the next year 2022, the company divis lab made Rs.8,879.82 Cr. of sales and Rs.2,948.54 Cr. of profit.
We are trying to predict a possible target that the shares of Divis Lab can cross in upcoming years. Our prediction is based upon different tools and terms which include Fibonacci retracement, support, and resistance. So, here we go with your possible targets for the upcoming years which are attached below.
|Year||Target Of Divi’s Lab|
When we read the technical charts we predict two possible targets which the share of Divis Lab can attain in the year 2022 first is around Rs.4,460 and after attaining these values share price will go down for a while but they will again move in an uptrend because of their product demand in the marked we will predict second possible target which they can cross is around Rs.5,150.
In the year 2023, we again going to predict two possible the target for the share price of Divis Lab which they can attain easily because of their research developed a product that is going to be a life-saving product for mankind so, we predict the first possible target is Rs.6,870 and the second possible target is around Rs.8,507.
As the charts show they will give good returns in future years to come so, here we predict the first target for the year 2024 is about Rs.9,502 and the second possible target which they can attain after showing some downtrend is about Rs.10,568.
As we read the chart for the year 2025, they will move in an uptrend which helps the share price of Divis Lab to increase their price. So, we predict the first target which they can get in the year 2025 is about Rs.11,824, and second, the possible target which they can cross in the same year is about Rs.13,364.
Till the end of this decade, Divis Lab will be the highest revenue-generating company in the pharmaceutical sector in South Asian Countries which include china too. So we predict the first possible target which they can attain in the year 2030 is around Rs.18,034 and the second possible target which they can cross till the end of this decade is around Rs.27,933.
In this article, We have done a detailed analysis of the Divis Lab. We were tried to include every aspect in our artical that is really essential to know before investing in any specific company shares.
Before ending this artical, I am going to tell you some strengths which help Divis Lab to emerge as the highest revenue-generating company at the end of this decade.
- Strong financial condition.
- 2. Socially active.
- 3. Brand value.
- 4. Advanced knowledge management.
- 5. More than 300 scientists working on research-based projects.
If you are having any doubts or questions regarding this artical, you can ask me in a comment section and share this artical with your friends and family members which help them to invest in the right companies and also us to reach millions of people.
I am a share market expert for the last five years. I have expertise in technical analysis, and fundamental analysis of stocks, and assets. On this website, I write content like analysis of shares, predict future targets of shares based on analysis, simplify technical analyses, and intraday trading.